Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Janssen Biotech presents DHODH inhibitors

May 4, 2021

Shanghai HaiHe Biopharma patents BRD4 inhibitors

May 4, 2021

First direct KRAS G12V(ON) inhibitors developed at Revolution Medicines

May 4, 2021

FDA approves IND for KRAS G12C inhibitor JAB-21822

May 4, 2021

Repare initiates phase I trial of oral PKMYT1 inhibitor RP-6306

May 3, 2021

Monte Rosa Therapeutics discloses new protein cereblon modulators

May 3, 2021

Patient dosing begins in phase Ib/II study of CFI-400945 in leukemia

May 3, 2021

A different path to specificity for Ras inhibitors

May 3, 2021

Phase IIb/III study of masitinib in metastatic CRPC meets primary endpoint

April 30, 2021

PRT-1419 shows potent antitumor activity in preclinical models

April 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...